Plan to Make Wales Smoke-Free by 2030

Aug.30.2022
Plan to Make Wales Smoke-Free by 2030
Wales plans to become a smoke-free country within eight years by implementing anti-smoking programs and cracking down on illegal tobacco sales.

According to reports, the Welsh government has recently formulated a plan to make Wales a smoke-free country in the next eight years.


The established goal of this plan is to have no more than 5% of adult population in Wales actively smoking by 2030. The plan includes implementing smoking cessation programs, exploring the use of e-cigarettes as a means of quitting smoking, and increasing efforts to combat the illegal tobacco market in Wales.


This article contains excerpts or reprints from third-party sources. The copyright belongs to the original media and author. If there is any infringement, please contact us for deletion. Any organization or individual who wishes to reprint must contact the author and should not directly reprint without permission.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

InterTabac 2025 Insights|Brands like NYSM and KIWI are promoting small-sized e-cigarettes, none of which feature screens
InterTabac 2025 Insights|Brands like NYSM and KIWI are promoting small-sized e-cigarettes, none of which feature screens
Inter Tabac 2025, held in Dortmund, Germany, took place from September 18th to 20th. 2Firsts observed that some booths, including those of NYSM, KIWI, Mevol, and FLERBAR, showcased small e-cigarettes. These devices were smaller or thinner than traditional disposable or cartridge-based e-cigarettes and lacked screen functionality.
Sep.23 by 2FIRSTS.ai
Product | Three Power Levels + “2+10” Setup: ELFBAR JoinOne Series Launches in UK Retail
Product | Three Power Levels + “2+10” Setup: ELFBAR JoinOne Series Launches in UK Retail
ELFBAR rolls out the JoinOne15 Classic prefilled replaceable-pod kit, now listed across multiple UK e-commerce channels (some pages marked “coming soon”). The device uses a “2 ml prefilled pod + 10 ml refill container (‘2+10’)” system, supports three power levels, and claims up to 15,000 puffs in combined use. The kit is priced at £12.99, with matching “2+10” refill pods at £7.99.
Nov.03 by 2FIRSTS.ai
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.
Nov.04
British American Tobacco to Open glo™ Ginza Flagship Store in Tokyo on October 18
British American Tobacco to Open glo™ Ginza Flagship Store in Tokyo on October 18
BAT Japan to open two-storey glo™ Ginza flagship on Oct 18, 2025; sales + members’ lounge, promos; near IQOS.
Oct.11 by 2FIRSTS.ai
NYS Youth Tobacco Use Down 29% Since 2022, Lowest Since 2000
NYS Youth Tobacco Use Down 29% Since 2022, Lowest Since 2000
According to the New York State Department of Health’s latest StatShot (Vol.17, #2025-1), high school tobacco product use in 2024 fell to 17.0%, the lowest rate since 2000, marking a 29% decline from 2022. E-cigarette use decreased from 18.7% to 13.1%, while cigarette use remained low at 2.4%.However, nicotine pouch use increased from 1.5% to 3.0%.
Oct.24 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai